|
1 Zhang J，Zheng A，Gong JL, et al.Study on the correlation between midkine expression and cervical cancer[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2008，4(4)：316-320. [张健，郑艾，巩俊玲，等．中期因子与宫颈癌的相关性研究[J/CD].中华妇幼临床医学杂志：电子版，2008，4(4)：316-320.]
|
|
2 Brookes AJ. The essence of SNPs[J]. Gene, 1999, 234(2)：177-186.
|
|
3 Matlashewski GJ, Tuck S, Pim D, et al. Primary structure polymorphism at amino acid residue 72 of human p53[J]. Mol Cell Biol, 1987, 7(2)：961-963.
|
|
4 Storey A, Thomas M, Kalita S, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer[J]. Nature, 1998, 393(6682)：229-234.
|
|
5 Jee SH, Won SY, Yun JE, et al. Polymorphism p53 codon-72 and invasive cervical cancer：A meta-analysis[J]. Int J Gynecol Obstet, 2004, 85(3)：301-308.
|
|
6 Roh J, Kim M, Kim J, et al. Polymorphisms in codon 31 of p21 and cervical cancer in Korean women[J]. Cancer Lett, 2001, 165(1)：59-62.
|
|
7 Tian QF，Ye F，Chen HZ, et al. Polymorphisms in codon 31 of p21 gene and cervical cancer susceptibility in Chinese Han women[J]. Prog Obstet Gynecol，2006，15(4)：269-271.[田其芳，叶枫，陈怀增，等．汉族妇女中p21codon31单核苷酸多态性与宫颈癌易感性关系的研究[J]．现代妇产科进展，2006，15(4)：269-271.]
|
|
8 Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles[J]. J Exp Med, 1993, 177(2)：557-560.
|
|
9 Lee YJ, Kim HY, Kim KH, et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea[J]. Cancer Lett, 2005, 225(2)：207-224.
|
|
10 Kamali-Sarvestani E, Merat A, Talei AR. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer[J]. Cancer Lett, 2005, 223(1)：113-119.
|
|
11 Selfart C, Slfart U, Plagens A, et al. Analysis of TNF-α，TNF-β，IL-6 and HSP-70 polymorphisms in patients with lung cancer[J]. Resp Med, 2005, 78(1)：152-160.
|
|
12 Skov L, Allen MH, Bang B, et al. Basal cell carcinoma is associated with high TNF-alpha release but nor with TNF-alpha polymorphism at position-308[J]. Exp Dermatol, 2003, 12(6)：772-776.
|
|
13 Deshpande A, Nolan JP, White PS, et al. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer[J]. J Infect Dis, 2005, 191(6)：969-976.
|
|
14 Parrella P, Seripa D, Matera MG, et al. Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection[J]. Eur J Epidemiol, 2007, 22(3)：159-162.
|
|
15 Guimaraes V, Guimaraes R, Brandao L, et al. Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women[J]. Hum Immunol, 2008, 69(4～5)：273-278.
|
|
16 Yang HL, Wang Q, Wang JL, et al. The association between IL-18 and rs1946519 in cervical cancer[J]. Guangdong Med J, 2007, 8(9)：1442-1443.[杨红玲，王前，王金龙，等. IL-18基因rs1946519位点与宫颈癌的关联性研究[J].广东医学，2007, 8(9)：1442-1443.]
|
|
17 Liu J, Xiong JH, Wu XX. Association of single nucleotide polymorphisms of human BLCAP gene and cervical carcinoma[J]. Basic Med Sci Clin, 2004, 24(6)：646-649.[刘娟，熊金虎，吴欣星.人BLCAP基因单核苷酸多态性与宫颈癌的相关性[J].基础医学与临床，2004, 24(6)：646-649.]
|
|
18 Zhang L, Liu J, Wu XX. An investigation of polymorphism in human BLCAP geneand their correlation with cervical carcinoma[J]. Med J Wuhan Univ, 2005, 26(4)：435-438.[张力，刘娟，伍欣星．宫颈癌高发人群BLCAP基因单核苷酸多态性检测[J].武汉大学学报(医学版), 2005, 26(4)：435-438.]
|
|
19 Nishioka Y, Sagae S, Nishikawa A, et al. A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression[J]. Cancer Lett, 2003, 200(1)：49-55.
|
|
20 Lai HC, Sytwu HK, Sun CA, et al. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis[J]. Int J Cancer, 2003, 103：221-225.
|
|
21 Chen YQ, Lv WG, Tian QF, et al. The single nucleotide polymorphisms of Fas-670 and cervical cancer susceptibility[J]. Natl Med J Chin, 2006, 86(39)：2792-2794.[陈雅卿，吕卫国，田其芳，等. Fas-670位点单核苷酸多态性与宫颈癌易感性关系的研究[J].中华医学杂志，2006, 86(39)：2792-2794.]
|
|
22 Engelmark MT, Renkema KY, Gyllensten UB, et al. No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ[J]. Int J Cancer, 2004, 112(6)：1084-1085.
|
|
23 Kang S, Dong SM, Seo SS, et al. FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer[J]. Cancer Genet Cytogenet, 2008, 180(1)：1-5.
|
|
24 Lee JY, Choi JY, Lee KM, et al. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women[J]. Clin Chem Acta, 2008, 389(1-2)：167-170.
|
|
25 Hong JM, Kim TH, Chae SC, et al. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population[J]. Osteoarthritis Cartilage, 2007, 15(6)：688-694.
|
|
26 Ollerenshaw M, Page T, Hammonds J, et al. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype[J]. Cancer Genet Cytogenet, 2004, 153(2)：122-126.
|
|
27 Konac E, Onen HI, Metindir J, et al. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers[J]. Cancer Detect Prev, 2007, 31(2)：102-109.
|
|
28 Chung HH, Kim MK, Kim JW, et al. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer[J]. Gynecol Oncol, 2006, 103(3)：1031-1037.
|